title: Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir.
abstract: The antiviral drug acyclovir, an analogue of purine, was found to selectively enhance the radiosensitivity of rodent tumor cells which were transduced with the herpes simplex virus thymidine kinase gene (HSV-tk). 9L rat glioma cells transduced with HSV-tk and treated with acyclovir (20 micrograms/ml) for 24 hr before or after irradiation were highly sensitive to radiation, as compared with non-transduced glioma cells. When 9L cells transduced with HSV-tk gene were exposed to acyclovir and radiation, the sensitizer enhancement ratio (SER) was 1.6. In vivo, a significant increase in the median survival time of rats with 9L-tk tumors was observed when acyclovir was administered before and after single-dose irradiation, relative to the survival time of similar rats receiving radiation alone. The results show that an antiviral agent can selectively enhance cell killing by radiation in cells transduced with the HSV-tk, and suggest that the addition of HSV-tk gene therapy to standard radiation therapy will improve the effectiveness of treatment for brain tumors.
authors.affiliation: Henry Ford Hospital, Department of Radiation Oncology, Detroit, MI 48202, USA.
authors.forename: S H
authors.initials: SH
authors.lastname: Kim
authors.forename: J H
authors.initials: JH
authors.lastname: Kim
authors.forename: A
authors.initials: A
authors.lastname: Kolozsvary
authors.forename: S L
authors.initials: SL
authors.lastname: Brown
authors.forename: S O
authors.initials: SO
authors.lastname: Freytag
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000628:therapy*; D002470:Cell Survival / Q000187:drug effects; D015774:Ganciclovir / Q000627:therapeutic use; D015316:Genetic Therapy; D005910:Glioma / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D018139:Simplexvirus / Q000201:enzymology / Q000235:genetics; D013937:Thymidine Kinase / Q000235:genetics; D014161:Transduction, Genetic
chemical_list: D000998:Antiviral Agents; D011838:Radiation-Sensitizing Agents; D013937:Thymidine Kinase; D015774:Ganciclovir; D000212:Acyclovir